Your browser doesn't support javascript.
loading
CD30L up-regulates CD30 and IL-4 expression by T cells.
Rossi, F M; Degan, M; Mazzocut-Zecchin, L; Di Francia, R; Aldinucci, D; Pinto, A; Gattei, V.
  • Rossi FM; Clinical and Experimental Hematology Research Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Via Pedemontana Occ.le 12, 33081 (PN), Aviano, Italy.
FEBS Lett ; 508(3): 418-22, 2001 Nov 23.
Article en En | MEDLINE | ID: mdl-11728464
ABSTRACT
CD30L is frequently expressed on acute myeloid leukemia (AML) blasts. Its presence is associated with the co-expression of interleukin-4 (IL-4) receptor and with the expansion of specific T-helper 2 (Th2) cell subsets producing IL-4 and expressing CD30. Recombinant CD30L-bearing cells up-regulated the expression of surface CD30 and increased the production of IL-4 and soluble (s) CD30 by co-cultured T cells. These findings were confirmed with AML blasts expressing surface CD30L, where blocking anti-CD30 antibodies completely abolished the release of sCD30 and reduced the production of IL-4. Our data indicates a direct role of CD30L(+) neoplastic cells in driving the immune response toward a Th2-polarized non-protective state.
Asunto(s)
Search on Google
Banco de datos: MEDLINE Asunto principal: Glicoproteínas de Membrana / Linfocitos T / Interleucina-4 / Antígeno Ki-1 / Células Th2 Límite: Animals / Humans Idioma: En Año: 2001 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Glicoproteínas de Membrana / Linfocitos T / Interleucina-4 / Antígeno Ki-1 / Células Th2 Límite: Animals / Humans Idioma: En Año: 2001 Tipo del documento: Article